Fintel reports that on October 8, 2024, HC Wainwright & Co. upgraded their outlook for Cassava Sciences (NasdaqCM:SAVA) from ...

Fintel reports that on October 7, 2024, HC Wainwright & Co. initiated coverage of DiaMedica Therapeutics (NasdaqCM:DMAC) with ...

Cassava Sciences (SAVA) stock earns its only buy rating on Wall Street as H.C. Wainwright upgrades the stock citing the company's recent SEC settlement. Read more here.

Equities research analysts at HC Wainwright lowered their Q3 2024 earnings per share estimates for Rhythm Pharmaceuticals in ...

Pharming Group (NASDAQ:PHAR – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 65.69% ...

Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform ...

The rise of artificial intelligence (AI) businesses has loomed large over finance markets in the past few months, pushing ...

The rise of artificial intelligence (AI) businesses has loomed large over finance markets in the past few months, pushing ...

(NASDAQ: FUFU, FUFU.WS) ("BitFuFu” or the "Company”) a fast-growing digital asset mining service and world-leading ...

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced that Mark Eisner, M.D., M.P.H., Executive Vice President and Chief ...